First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data

Atrial Fibrillation Clinical Trial

— FACTS  

Official title:

First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01161589
• Other study ID #: FACTS S-ICD
• Status: Completed
• Phase: N/A
• First received: July 12, 2010
• Last updated: February 14, 2017
• Start date: October 2005
• Est. completion date: November 2008

Study information

• Verified date: February 2017
• Source: Boston Scientific Corporation
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this clinical study is to collect simultaneous, multiple view cardiac signals representing both transvenous ICDs (T-ICD) and sensing vectors from the subcutaneous implantable defibrillator system (S-ICD). Upon completion, this data will represent the first true database capable of comparing detection characteristics of transvenous and subcutaneous ICDs. Future protocols will be created to dictate the specific methods of such comparisons.

Description:

The FACTS S-ICD study is a data gathering study that takes place during the implant procedure of a standard T-ICD system. Patients undergoing a routine dual chamber, dual high voltage shocking coil T-ICD or CRT-D insertion or replacement will be connected to an external data recorder via sterile cables. Atrial and ventricular arrhythmias will be induced while multiple ECG views are simultaneously recorded from both intracardiac and surface vectors. These episodes will then be digitized to create the FACTS S-ICD arrhythmia library.

As both dedicated and integrated bipolar sensing configurations are currently utilized in the marketplace, data will be collected using both market available ICD sensing methods.

The FACTS S-ICD study will enroll a sufficient quantity of patients such that a minimum of 50 atrial and 50 ventricular arrhythmic episodes are collected via both dedicated and integrated ICD systems. S-ICD signals will be collected for all recorded episodes.

The T-ICD implant procedure will be completed as per normal hospital practice and no further patient dependent data gathering will be required past the implant surgery and point of surgery arrhythmia inductions.

INCLUSION CRITERIA

1. Age 18 or above, or legal age to give consent specific to state and national law.

2. Any patient undergoing a clinically indicated initial dual chamber T-ICD or CRT-D implantation. In addition, patients who require replacement of an existing dual chamber T-ICD or CRT-D system will be eligible for enrollment in the study.

3. Patient will have a subcutaneous, left pectoral defibrillator implant.

EXCLUSION CRITERIA

1. Patients unable or unwilling to provide informed consent.

2. Any condition which precludes the subject's ability to comply with the study requirements, including completion of the study.

3. Patients in chronic atrial fibrillation who have not been in sinus rhythm within the last six months.

4. Enrollment in a concurrent study, without Cameron Health's written approval, that may confound the results of this study.

5. Women who are pregnant or who are trying to become pregnant Note: Women of child bearing potential must have a negative pregnancy test within 7 days prior to defibrillator implant.

6. Patient requires left sub-muscular or right sided defibrillator implant

Recruitment information / eligibility

• Status: Completed
• Enrollment: 142
• Est. completion date: November 2008
• Est. primary completion date: November 2008
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18 or above, or legal age to give consent specific to state and national law.

• Any patient undergoing a clinically indicated initial dual chamber T-ICD or CRT-D implantation. In addition, patients who require replacement of an existing dual chamber T-ICD or CRT-D system will be eligible for enrollment in the study.

• Patient will have a subcutaneous, left pectoral defibrillator implant

Exclusion Criteria:

• Patients unable or unwilling to provide informed consent.

• Any condition which precludes the subject's ability to comply with the study requirements, including completion of the study.

• Patients in chronic atrial fibrillation who have not been in sinus rhythm within the last six months.

• Enrollment in a concurrent study, without Cameron Health's written approval, that may confound the results of this study.

• Women who are pregnant or who are trying to become pregnant Note: Women of child bearing potential must have a negative pregnancy test within 7 days prior to defibrillator implant.

• Patient requires left sub-muscular or right sided defibrillator implant

Related Conditions & MeSH terms

• Atrial Fibrillation
• Tachycardia
• Tachycardia, Ventricular
• Ventricular Fibrillation
• Ventricular Tachycardia

Locations

Country	Name	City	State
Netherlands	Erasmus Medical Centre	Rotterdam
United States	Medical University of South Carolina	Charleston	South Carolina
United States	University of Chicago	Chicago	Illinois
United States	Virginia Commonwealth University	Richmond	Virginia

Sponsors (1)

Lead Sponsor	Collaborator
Boston Scientific Corporation

Countries where clinical trial is conducted

United States,  Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Collection of simultaneous cardiac signals representing S-ICD and ICD sensing vectors	This study will enroll a sufficient number of patients such that a minimum of 50 atrial and 50 ventricular arrhythmic episodes are collected by dedicated and integrated ICD systems and by the simulated S-ICD system	3 years